Q

Qingdao NovelBeam Technology Co Ltd
SSE:688677

Watchlist Manager
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Watchlist
Price: 35.68 CNY -7.76% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Qingdao NovelBeam Technology Co Ltd?
Write Note

Qingdao NovelBeam Technology Co Ltd
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Qingdao NovelBeam Technology Co Ltd
Total Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Total Current Liabilities
ÂĄ85.4m
CAGR 3-Years
3%
CAGR 5-Years
15%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Total Current Liabilities
ÂĄ588.2m
CAGR 3-Years
75%
CAGR 5-Years
65%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Total Current Liabilities
ÂĄ2.9B
CAGR 3-Years
11%
CAGR 5-Years
23%
CAGR 10-Years
22%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Total Current Liabilities
ÂĄ12.9B
CAGR 3-Years
18%
CAGR 5-Years
22%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Total Current Liabilities
ÂĄ1B
CAGR 3-Years
51%
CAGR 5-Years
31%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Total Current Liabilities
ÂĄ5.8B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Qingdao NovelBeam Technology Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Health Care

Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 854 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
56.99 CNY
Undervaluation 37%
Intrinsic Value
Price
Q

See Also

What is Qingdao NovelBeam Technology Co Ltd's Total Current Liabilities?
Total Current Liabilities
85.4m CNY

Based on the financial report for Dec 31, 2023, Qingdao NovelBeam Technology Co Ltd's Total Current Liabilities amounts to 85.4m CNY.

What is Qingdao NovelBeam Technology Co Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
15%

Over the last year, the Total Current Liabilities growth was -49%. The average annual Total Current Liabilities growth rates for Qingdao NovelBeam Technology Co Ltd have been 3% over the past three years , 15% over the past five years .

Back to Top